Organon (OGN) Interest Coverage Ratio (2021 - 2026)

Organon (OGN) recorded quarterly Interest Coverage Ratio of 2.12 in Q1 2026, up 21.99% quarter-over-quarter from 1.74 in Q4 2025, and up 9.84% on a YoY basis from 1.93 in Q1 2025.

Organon (OGN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends

Organon's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 2.12 for Q1 2026.

  • In Q1 2026, Interest Coverage Ratio rose 9.84% year-over-year to 2.12; the TTM figure through Mar 2026 stood at 2.3 (down 11.07% YoY), while the FY2025 annual figure was 2.24, up 590.48% from the prior year.
  • Interest Coverage Ratio was 2.12 for Q1 2026 at Organon, up from 1.74 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 3.26 in Q3 2024 to a low of 4.49 in Q4 2023.
  • Historically, Interest Coverage Ratio has averaged 0.51 across 5 years, with a median of 1.23 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio tumbled 113.04% in 2023, then soared 200.76% in 2024.
  • A 5-year view of Interest Coverage Ratio shows it stood at 4.06 in 2022, then slipped by 10.58% to 4.49 in 2023, then soared by 148.61% to 2.18 in 2024, then dropped by 20.45% to 1.74 in 2025, then grew by 21.99% to 2.12 in 2026.
  • The last three Interest Coverage Ratio figures came in at 2.12 (Q1 2026), 1.74 (Q4 2025), and 2.8 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn -13.73
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn -
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn 23.39
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn -
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn -
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn 4.06
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn 10.78
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn -
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn -
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 2.12

Historic Data

Download Data
DateValue
Mar 31, 2026 2.12
Dec 31, 2025 1.74
Sep 30, 2025 2.80
Jun 30, 2025 2.47
Mar 31, 2025 1.93
Dec 31, 2024 2.18
Sep 30, 2024 3.26
Jun 30, 2024 2.95
Mar 31, 2024 -3.27
Dec 31, 2023 -4.49
Sep 30, 2023 -3.97
Jun 30, 2023 -2.92
Mar 31, 2023 -2.61
Dec 31, 2022 -4.06
Sep 30, 2022 -2.49
Jun 30, 2022 -3.07
Mar 31, 2022 -1.23
Dec 31, 2021 -3.70
Sep 30, 2021 -2.24
Jun 30, 2021 -2.35